Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease


Autoria(s): Samonakis, D. N.; Quaglia, A.; Joshi, N. M.; Tibballs, J. M.; Nagree, A.; Triantos, C. K.; Davies, N.; Standish, R. A.; Dhillon, A. P.; Davidson, B. R.; Burroughs, A. K.; Caplin, M. E.
Data(s)

01/11/2005

Resumo

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder, with variable clinical manifestations and unpredictable course, associated with an increased incidence of various tumours. Plexiform neurofibromas are hallmark lesions of NF1; they are slow-growing tumours, which account for substantial morbidity, including disfigurement and functional impairment, and may even be life-threatening. Neuroendocrine tumours (NETs), a rare diverse group of neoplasms, are occasionally associated with neurofibromatosis. Pancreatic NETs are tumours with an incidence of less than 1/100 000 population/year and complex patterns of behaviour, which often need complicated strategies for optimal management. We present the case of a young adult with NF1, having a unique concurrence of plexiform neurofibroma involving the liver with an ampullary NET, and we discuss step by step the management in a specialist centre.<br />

Identificador

http://hdl.handle.net/10536/DRO/DU:30028209

Idioma(s)

eng

Publicador

Lippincott Williams & Wilkins Inc

Relação

http://journals.lww.com/eurojgh/Abstract/2005/11000/Obstructive_jaundice_secondary_to_neuroendocrine.12.aspx

Direitos

2005, Lippincott Williams & Wilkins, Inc.

Tipo

Journal Article